Evidence map›Paper›PMID 29170564›Full record

ArticleJournal of the Electrochemical Society2017

INTEGRATED MICROFLUIDIC SELEX USING FREE SOLUTION ELECTROKINETICS.

Timothy R Olsen, Claudia Tapia-Alveal, Kyung-Ae Yang, Xin Zhang, Leonardo Joe Pereira, Nickolaos Farmakidis, Renjun Pei, Milan N Stojanovic, Qiao Lin

Abstract read
In one paragraph

Article in Journal of the Electrochemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. SELEX-based DNA Aptamer Selection: A Perspective from the Advancement of Separation Techniques.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2021
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Timothy R OlsenDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Claudia Tapia-AlvealDepartment of Medicine, Columbia University, New York, NY, USA.
Kyung-Ae YangDepartment of Medicine, Columbia University, New York, NY, USA.
Xin ZhangDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Leonardo Joe PereiraDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Nickolaos FarmakidisDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Renjun PeiSuzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.
Milan N StojanovicDepartment of Medicine, Columbia University, New York, NY, USA.
Qiao LinDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.

Funding

Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
TR&D 3P41EB002033 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BRENNER, DAVID JONATHAN · 2003 to 2018
$17.0M
NRSA Training CoreTL1TR001875 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPANN, MARISA N, TAYLOR, JACQUELYN Y · 2016 to 2025
$8.9M
Theranostic Nano-objects: Basic Principles and Initial ApplicationsR01GM104960 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STOJANOVIC, MILAN N, YAN, HAO · 2012 to 2016
$5.4M
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple MyelomaR33CA196470 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIN, QIAO · 2016 to 2018
$1.2M
Clinical and Translational Science AwardTL1TR000082 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$732k
Automated Microfluidic Selection of Aptamers against CarbohydratesR21CA199849 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STOJANOVIC, MILAN N · 2015 to 2016
$612k
Microfluidic Selection of Aptamers for Biological Purification ApplicationsR21GM104204 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIN, QIAO · 2012 to 2012
$196k
NCATS NIH HHS TL1 TR000082NCATS NIH HHS TL1 TR001875NCATS NIH HHS UL1 TR000040NCI NIH HHS R21 CA199849NCI NIH HHS R33 CA196470NIBIB NIH HHS P41 EB002033NIGMS NIH HHS R01 GM104960NIGMS NIH HHS R21 GM104204
6 · The paper itself

Abstract

Systematic evolution of ligands by exponential enrichment (SELEX) offers a powerful method to isolate affinity oligonucleotides known as aptamers, which can then be used in a wide range of applications from drug delivery to biosensing. However, conventional SELEX methods rely on labor intensive and time consuming benchtop operations. A simplified microfluidic approach is presented which allows integration of the affinity selection and amplification stages of SELEX for the isolation of target-binding oligonucleotides by combining bead-based biochemical reactions with free solution electrokinetic oligonucleotide transfer. Free solution electrokinetics allows coupling of affinity selection and amplification for closed loop oligonucleotide enrichment without the need for offline processes, flow handling components or gel components, while bead based selection and amplification allow efficient manipulation of reagents and reaction products thereby realizing on-chip loop closure and integration of the entire SELEX process. Thus the approach is capable of multi-round enrichment of oligonucleotides using simple transfer processes while maintaining a high level of device integration, as demonstrated by the isolation of an aptamer pool against a protein target (IgA) with significantly higher binding affinity than the starting library in approximately 4 hours of processing time.

Identifiers

PMID29170564
PMCPMC5697788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.